List Name |
Annotation |
Enrichment |
p-value |
unfolded protein response |
AmiGO Browser |
26.97 |
2.46e-03 |
ER-nuclear signaling pathway |
AmiGO Browser |
20.23 |
4.38e-03 |
fibroblast growth factor receptor signaling pathway |
AmiGO Browser |
14.45 |
8.48e-03 |
fatty acid biosynthetic process |
AmiGO Browser |
6.67 |
0.01 |
carboxylic acid biosynthetic process |
AmiGO Browser |
6.07 |
0.01 |
organic acid biosynthetic process |
AmiGO Browser |
6.07 |
0.01 |
sensory organ development |
AmiGO Browser |
6.01 |
0.01 |
lipid biosynthetic process |
AmiGO Browser |
3.38 |
0.02 |
negative regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
4.03 |
0.02 |
response to hypoxia |
AmiGO Browser |
9.41 |
0.02 |
positive regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
3.58 |
0.03 |
respiratory gaseous exchange |
AmiGO Browser |
7.78 |
0.03 |
inner ear development |
AmiGO Browser |
7.63 |
0.03 |
interphase of mitotic cell cycle |
AmiGO Browser |
4.53 |
0.03 |
interphase |
AmiGO Browser |
4.40 |
0.03 |
ear development |
AmiGO Browser |
7.10 |
0.03 |
regulation of progression through mitotic cell cycle |
AmiGO Browser |
7.10 |
0.03 |
cytochrome c oxidase complex assembly |
AmiGO Browser |
28.90 |
0.03 |
cell redox homeostasis |
AmiGO Browser |
6.74 |
0.04 |
positive regulation of transcription, DNA-dependent |
AmiGO Browser |
2.75 |
0.04 |
Mo-molybdopterin cofactor metabolic process |
AmiGO Browser |
25.28 |
0.04 |
Mo-molybdopterin cofactor biosynthetic process |
AmiGO Browser |
25.28 |
0.04 |
molybdopterin cofactor metabolic process |
AmiGO Browser |
25.28 |
0.04 |
molybdopterin cofactor biosynthetic process |
AmiGO Browser |
25.28 |
0.04 |
tube development |
AmiGO Browser |
3.99 |
0.04 |
branching morphogenesis of a tube |
AmiGO Browser |
6.22 |
0.04 |
morphogenesis of a branching structure |
AmiGO Browser |
6.13 |
0.04 |
Notch signaling pathway |
AmiGO Browser |
6.13 |
0.04 |
regulation of cell redox homeostasis |
AmiGO Browser |
22.47 |
0.04 |
regulation of cyclic nucleotide biosynthetic process |
AmiGO Browser |
22.47 |
0.04 |
mating behavior |
AmiGO Browser |
22.47 |
0.04 |
regulation of cAMP metabolic process |
AmiGO Browser |
22.47 |
0.04 |
regulation of nucleotide biosynthetic process |
AmiGO Browser |
22.47 |
0.04 |
embryonic morphogenesis |
AmiGO Browser |
3.77 |
0.05 |
respiratory tube development |
AmiGO Browser |
5.78 |
0.05 |
in utero embryonic development |
AmiGO Browser |
5.78 |
0.05 |
postreplication repair |
AmiGO Browser |
20.23 |
0.05 |
copper ion homeostasis |
AmiGO Browser |
20.23 |
0.05 |
negative regulation of nucleotide metabolic process |
AmiGO Browser |
20.23 |
0.05 |
embryonic development |
AmiGO Browser |
2.55 |
0.05 |
embryonic appendage morphogenesis |
AmiGO Browser |
5.54 |
0.05 |
embryonic limb morphogenesis |
AmiGO Browser |
5.54 |
0.05 |
regulation of DNA repair |
AmiGO Browser |
18.39 |
0.05 |
neurotransmitter uptake |
AmiGO Browser |
18.39 |
0.05 |
regulation of cyclic nucleotide metabolic process |
AmiGO Browser |
18.39 |
0.05 |
visual behavior |
AmiGO Browser |
18.39 |
0.05 |
leukocyte degranulation |
AmiGO Browser |
18.39 |
0.05 |
limb morphogenesis |
AmiGO Browser |
5.32 |
0.05 |
appendage morphogenesis |
AmiGO Browser |
5.32 |
0.05 |
appendage development |
AmiGO Browser |
5.32 |
0.05 |
response to DNA damage stimulus |
AmiGO Browser |
2.45 |
0.06 |
acidic amino acid transport |
AmiGO Browser |
16.86 |
0.06 |
glutamate transport |
AmiGO Browser |
16.86 |
0.06 |
positive regulation of gene-specific transcription |
AmiGO Browser |
16.86 |
0.06 |
sulfate transport |
AmiGO Browser |
16.86 |
0.06 |
negative regulation of transcription, DNA-dependent |
AmiGO Browser |
2.77 |
0.06 |
gland development |
AmiGO Browser |
4.99 |
0.06 |
regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
2.02 |
0.06 |
neuromuscular process |
AmiGO Browser |
15.56 |
0.06 |
regulation of nucleotide metabolic process |
AmiGO Browser |
15.56 |
0.06 |
pteridine and derivative biosynthetic process |
AmiGO Browser |
15.56 |
0.06 |
RNA elongation from RNA polymerase II promoter |
AmiGO Browser |
15.56 |
0.06 |
aromatic compound biosynthetic process |
AmiGO Browser |
15.56 |
0.06 |
embryonic organ morphogenesis |
AmiGO Browser |
15.56 |
0.06 |
T cell differentiation in the thymus |
AmiGO Browser |
15.56 |
0.06 |
thymic T cell selection |
AmiGO Browser |
15.56 |
0.06 |
transcription from RNA polymerase II promoter |
AmiGO Browser |
1.83 |
0.06 |
response to protein stimulus |
AmiGO Browser |
4.87 |
0.06 |
response to unfolded protein |
AmiGO Browser |
4.87 |
0.06 |
protein retention in ER |
AmiGO Browser |
14.45 |
0.07 |
mast cell activation |
AmiGO Browser |
14.45 |
0.07 |
monocarboxylic acid metabolic process |
AmiGO Browser |
2.64 |
0.07 |
enzyme linked receptor protein signaling pathway |
AmiGO Browser |
2.31 |
0.07 |
positive regulation of transcription |
AmiGO Browser |
2.30 |
0.07 |
behavioral interaction between organisms |
AmiGO Browser |
13.48 |
0.07 |
isoprenoid biosynthetic process |
AmiGO Browser |
13.48 |
0.07 |
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
2.25 |
0.07 |
pteridine and derivative metabolic process |
AmiGO Browser |
12.64 |
0.08 |
G2 phase of mitotic cell cycle |
AmiGO Browser |
12.64 |
0.08 |
G2 phase |
AmiGO Browser |
12.64 |
0.08 |
reproductive behavior |
AmiGO Browser |
12.64 |
0.08 |
response to endogenous stimulus |
AmiGO Browser |
2.23 |
0.08 |
cell maturation |
AmiGO Browser |
4.30 |
0.08 |
specification of organ identity |
AmiGO Browser |
11.90 |
0.08 |
cell-cell signaling during cell fate commitment |
AmiGO Browser |
11.90 |
0.08 |
induction of an organ |
AmiGO Browser |
11.90 |
0.08 |
induction |
AmiGO Browser |
11.90 |
0.08 |
RNA elongation |
AmiGO Browser |
11.90 |
0.08 |
T cell selection |
AmiGO Browser |
11.24 |
0.09 |
patterning of blood vessels |
AmiGO Browser |
11.24 |
0.09 |
mammary gland development |
AmiGO Browser |
11.24 |
0.09 |
response to ionizing radiation |
AmiGO Browser |
11.24 |
0.09 |
negative regulation of metabolic process |
AmiGO Browser |
1.97 |
0.09 |
tube morphogenesis |
AmiGO Browser |
4.05 |
0.09 |
angiogenesis |
AmiGO Browser |
2.86 |
0.09 |
positive regulation of erythrocyte differentiation |
AmiGO Browser |
10.65 |
0.09 |
traversing start control point of mitotic cell cycle |
AmiGO Browser |
10.65 |
0.09 |
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
2.12 |
0.09 |
G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) |
AmiGO Browser |
3.97 |
0.09 |
apoptosis |
AmiGO Browser |
1.69 |
0.09 |
transmembrane receptor protein serine/threonine kinase signaling pathway |
AmiGO Browser |
3.89 |
0.09 |
programmed cell death |
AmiGO Browser |
1.68 |
0.09 |
neuromuscular junction development |
AmiGO Browser |
10.11 |
0.09 |
positive regulation of anti-apoptosis |
AmiGO Browser |
10.11 |
0.09 |
vasoconstriction |
AmiGO Browser |
10.11 |
0.09 |
auditory receptor cell differentiation |
AmiGO Browser |
10.11 |
0.09 |
inner ear receptor cell differenation |
AmiGO Browser |
10.11 |
0.09 |
pattern specification process |
AmiGO Browser |
2.78 |
0.09 |
regulation of apoptosis |
AmiGO Browser |
1.80 |
0.10 |
axon cargo transport |
AmiGO Browser |
9.63 |
0.10 |
cell aging |
AmiGO Browser |
9.63 |
0.10 |
mRNA polyadenylation |
AmiGO Browser |
9.63 |
0.10 |
mating |
AmiGO Browser |
9.63 |
0.10 |
regulation of programmed cell death |
AmiGO Browser |
1.79 |
0.10 |
neuron recognition |
AmiGO Browser |
9.19 |
0.10 |
microtubule-based movement |
AmiGO Browser |
3.68 |
0.10 |
cell fate commitment |
AmiGO Browser |
3.64 |
0.10 |